Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

JAMA Oncol. 2022 Jun 1;8(6):1-2. doi: 10.1001/jamaoncol.2022.1467.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BNT162 Vaccine
  • Humans
  • Neoplasms*
  • Vaccines*

Substances

  • Vaccines
  • BNT162 Vaccine